Our grant calls
We fund pioneering research through regular grant calls that set out specific challenges for the research community.
-
BEACON2 2025 Request for ApplicationsThis funding will support up to three pre-clinical studies into new drug combinations for treating relapsed neuroblastoma.
-
ACTION 2022 Request for ApplicationsWe launched our biggest ever grant call with the ACTION consortium in 2022.
-
UK neuroblastoma research initiative 2021Read more about our UK research initiative and its outcome.
-
International neuroblastoma research initiative 2019Learn more about our 2019 grant call and the two projects funded.
-
International neuroblastoma research initiative 2018Learn more about our 2018 grant call and the transatlantic project funded.